Histoplasmosis and Acquired Immunodeficiency Syndrome: A Study of Prognostic Factors

Clinical Infectious Diseases

Volumn 38, Issue 1, 2004, Pages 134-138

  Couppié, Pierre ^a,b,e,f,g   Sobesky, Milko ^f,g   Aznar, Christine ^c,g   Bichat, Saravane ^d   Clyti, Emmanuel ^b   Bissuel, François ^e,f,g   El Guedj, Myriam ^e,f   Alvarez, Fernand ^h   Demar, Magali ^c,g   Louvel, Dominique ^d   Pradinaud, Roger ^a,b   Carme, Bernard ^c,g  

^a CH de Cayenne   (French Guiana)

^b Inst Guyanais de Dermatol Trop   (French Guiana)

^c Serv Hosp Univ Parasitol Mycol   (French Guiana)

^d Service de Médecine B   (French Guiana)

^e CENTRE HOSPITALIER DE CAYENNE   (French Guiana)

^f Ctr d'Info Soins l'I   (French Guiana)

^g UNIVERSITÉ DES ANTILLES ET DE LA GUYANE   (France)

^h Kourou Medico Surgical Center   (French Guiana)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; LACTATE DEHYDROGENASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DYSPNEA; FEMALE; HISTOPLASMOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; FEMALE; HISTOPLASMOSIS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 9144273356     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/379770     Document Type: Article

References (13)

1. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine 1990; 69:361-74.
2. Wheat J, Hafner R, Korzun AH, et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Med 1995; 98:336-42.
3. Wheat LJ. Histoplasmosis in the acquired immunodeficiency syndrome. Curr Top Med Mycol 1996; 7:7-18.
4. Wheat J, Ma Whinney S, Hafner R, et al. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. Am J Med 1997; 103:223-32.
5. Johnson PC, Wheat LJ, Cloud GA, et al. Safety and efficacy of liposomal amphotericin 13 compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 2002; 137:105-9.
6. Mocherla S, Wheat LJ. Treatment of histoplasmosis. Semin Respir Infect 2001; 16:141-8.
7. Wheat LJ, Cloud G, Johnson PC, et al. Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole. Antimicrob Agents Chemother 2001; 45:2354-7.
8. Wheat LJ, Chetchotisakd P, Williams B, et al. Factors associated with severe manifestations of histoplasmosis in AIDS. Clin Infect Dis 2000; 30:877-81.
9. Sobesky M, Dabis F, Le Beux P. HIV/AIDS epidemic in French Guiana: 1979-1997. J Acquir Immune Defic Syndr 2000; 24:178-81.
10. Silverie C, Duchassin M. Enquête sur l'incidence en Guyane Française de l'histpoplasmose en milieu militaire au moyen de tests cutanés à Phistoplasmine. Bull Soc Pathol Exot 1966; 59:199-207.
11. Casanova-Cardiel LJ, Ruiz-Ordaz I. Hisloplasma capsulatum en sangre periferica de pacientes con SIDA. Informe de cuatro casos con elevacion de deshidroogenasa lactica. Rev Invest Clin 1993; 45:67-70.
12. Corcoran GR, Al-Abdely H, Flanders CD, et al. Markedly elevated serum lactate dehydrogenase levels are a clue to the diagnosis of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis 1997; 24:942-4.
13. Koduri PR, Chundi V, De Marais P, et al. Reactive hemophagocytic syndrome : a new presentation of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis 1995; 21:1463-5.